PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: MARKET SEGMENTATION BY APPLICATION • Segmentation by application • Comparison by application • Global infertility treatment market by male infertility treatment • Global infertility treatment market by female infertility treatment • Market opportunity by application PART 08: CUSTOMER LANDSCAPE PART 09: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Infertility treatment market in Americas • Infertility treatment market in EMEA • Infertility treatment market in APAC • Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 12: MARKET TRENDS • Emergence of digital innovations • Growing acceptance of same-sex marriages • Growing online retail sales of drugs PART 13: VENDOR LANDSCAPE • Overview • Landscape disruption PART 14: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • AbbVie • Cook Group • Ferring • Merck • The Cooper Companies • Vitrolife PART 15: APPENDIX • List of abbreviations Exhibit 01: Related market: global healthcare market Exhibit 02: Market characteristics Exhibit 03: Market segments Exhibit 04: Market definition - Inclusions and exclusions checklist Exhibit 05: Market size 2017 Exhibit 06: Validation techniques employed for market sizing 2017 Exhibit 07: Global infertility treatment market – Market size and forecast 2017-2022 ($ bn) Exhibit 08: Global infertility treatment market – Year over year growth 2018-2022 (%) Exhibit 09: Five forces analysis 2017 Exhibit 10: Five forces analysis 2022 Exhibit 11: Bargaining power of buyers Exhibit 12: Bargaining power of suppliers Exhibit 13: Threat of new entrants Exhibit 14: Threat of substitutes Exhibit 15: Threat of rivalry Exhibit 16: Market condition - Five forces 2017 Exhibit 17: Global infertility treatment market by application – Market share 2017-2022 (%) Exhibit 18: Comparison by application Exhibit 19: Global infertility treatment market by male infertility treatment – Market size and forecast 2017-2022 ($ bn) Exhibit 20: Global infertility treatment market by male infertility treatment – Year over year growth 2018-2022 (%) Exhibit 21: Global infertility treatment market by female infertility treatment – Market size and forecast 2017-2022 ($ bn) Exhibit 22: Global infertility treatment market by female infertility treatment – Year over year growth 2018-2022 (%) Exhibit 23: Market opportunity by application Exhibit 24: Customer landscape Exhibit 25: Global infertility treatment market by region – Market share 2017-2022 (%) Exhibit 26: Regional comparison Exhibit 27: Infertility treatment market in Americas – Market size and forecast 2017-2022 ($ bn) Exhibit 28: Infertility treatment market in Americas – Year over year growth 2018-2022 (%) Exhibit 29: Top three countries in Americas Exhibit 30: Infertility treatment market in EMEA – Market size and forecast 2017-2022 ($ bn) Exhibit 31: Infertility treatment market in EMEA – Year over year growth 2018-2022 (%) Exhibit 32: Top three countries in EMEA Exhibit 33: Infertility treatment market in APAC – Market size and forecast 2017-2022 ($ bn) Exhibit 34: Infertility treatment market in APAC – Year over year growth 2018-2022 (%) Exhibit 35: Top three countries in APAC Exhibit 36: Market opportunity Exhibit 37: Cost breakdown of IVF by various stages in US Exhibit 38: Top mobile applications improving infertility awareness Exhibit 39: Vendor landscape Exhibit 40: Landscape disruption Exhibit 41: Vendors covered Exhibit 42: Vendor classification Exhibit 43: Market positioning of vendors Exhibit 44: AbbVie: Vendor overview Exhibit 45: AbbVie – Business segments Exhibit 46: AbbVie – Organizational developments Exhibit 47: AbbVie – Geographic focus Exhibit 48: AbbVie – Segment focus Exhibit 49: AbbVie – Key offerings Exhibit 50: Cook Group: Vendor overview Exhibit 51: Cook Group – Business segments Exhibit 52: Cook Group – Organizational developments Exhibit 53: Cook Group – Geographic focus Exhibit 54: Cook Group – Segment focus Exhibit 55: Cook Group – Key offerings Exhibit 56: Ferring: Vendor overview Exhibit 57: Ferring – Business segments Exhibit 58: Ferring – Organizational developments Exhibit 59: Ferring – Geographic focus Exhibit 60: Ferring – Segment focus Exhibit 61: Ferring – Key offerings Exhibit 62: Merck: Vendor overview Exhibit 63: Merck – Business segments Exhibit 64: Merck – Organizational developments Exhibit 65: Merck – Geographic focus Exhibit 66: Merck – Segment focus Exhibit 67: Merck – Key offerings Exhibit 68: The Cooper Companies: Vendor overview Exhibit 69: The Cooper Companies – Business segments Exhibit 70: The Cooper Companies – Organizational developments Exhibit 71: The Cooper Companies – Geographic focus Exhibit 72: The Cooper Companies – Segment focus Exhibit 73: The Cooper Companies – Key offerings Exhibit 74: Vendor overview Exhibit 75: Vitrolife – Business segments Exhibit 76: Vitrolife – Organizational developments Exhibit 77: Vitrolife – Geographic focus Exhibit 78: Vitrolife – Segment focus Exhibit 79: Vitrolife – Key offerings

AbbVie, Cook Group, Ferring, Merck, The Cooper Companies, and Vitrolife.